When is a switch to a basal-bolus regimen appropriate for type 2 diabetes?

When is a switch to a basal-bolus regimen appropriate for type 2 diabetes?

• A. When lifestyle changes and non-insulin meds fail to meet targets, or patient has severe hyperglycemia requiring insulin.
• B. Immediately after diagnosis.
• C. Only when patient ages >80.
• D. Only if patient has DKA.

Answer: (A)

Basal-bolus insulin therapy is used when the goal cannot be reached with lifestyle changes and non-insulin medications, or when blood glucose is severely high and requires insulin to bring it under control. The idea behind this approach is to split dosing into a steady, background insulin (basal) that keeps fasting glucose in check and small, rapid-acting doses (bolus) before meals to handle the rises after eating. This allows for flexible, tighter control of both fasting and post-meal glucose levels, which is especially important when targets aren’t met with other therapies or when hyperglycemia is pronounced. It isn’t started automatically right after diagnosis, nor is it limited to very old patients or to cases of DKA. Those situations don’t define when a switch to basal-bolus is appropriate. If a patient has persistent high A1C despite optimized non-insulin therapy, or presents with severe hyperglycemia requiring insulin, basal-bolus becomes a thoughtful option to achieve better overall control and flexibility.

Basal-bolus insulin therapy is used when the goal cannot be reached with lifestyle changes and non-insulin medications, or when blood glucose is severely high and requires insulin to bring it under control. The idea behind this approach is to split dosing into a steady, background insulin (basal) that keeps fasting glucose in check and small, rapid-acting doses (bolus) before meals to handle the rises after eating. This allows for flexible, tighter control of both fasting and post-meal glucose levels, which is especially important when targets aren’t met with other therapies or when hyperglycemia is pronounced.

It isn’t started automatically right after diagnosis, nor is it limited to very old patients or to cases of DKA. Those situations don’t define when a switch to basal-bolus is appropriate. If a patient has persistent high A1C despite optimized non-insulin therapy, or presents with severe hyperglycemia requiring insulin, basal-bolus becomes a thoughtful option to achieve better overall control and flexibility.